Amendment to Statement of Changes in Beneficial Ownership (Form 4/A)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * KANDERS WARREN B 2. Issuer Name and Ticker or Trading Symbol Cadre Holdings, Inc. [CDRE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CEO AND CHAIRMAN (Last) (First) (Middle) C/O KANDERS & COMPANY, INC., 250 ROYAL PALM WAY, SUITE 201 3. Date of Earliest Transaction (Month/Day/Year) 03/13/2025 (Street) PALM BEACH, FL 33480 4. If Amendment, Date Original Filed (Month/Day/Year) 03/17/2025 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option (right to purchase)

$33.85

03/13/2025

A

117,457

(1)(3)

03/13/2035

Common Stock

117,457

$ 0

117,457

D

Restricted Stock Units

(2)(3)

03/13/2025

A

37,666

(2)(3)

(2)(3)

Common Stock

37,666

$ 0

37,666

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
KANDERS WARREN B C/O KANDERS & COMPANY, INC. 250 ROYAL PALM WAY, SUITE 201 PALM BEACH, FL 33480	X	X	CEO AND CHAIRMAN

Signatures

/s/ Warren B. Kanders		04/24/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The option to purchase 117,457 shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), was granted under the Plan. Options to purchase 39,153 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 39,152 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively.
(2)	Comprised of a restricted stock units award granted under the Plan consisting of 37,666 restricted shares of the Issuer's Common Stock. 12,556 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,555 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively.
(3)	This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 6 and 7 have been renumbered and revised accordingly.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.